T 0446/16 of 12.03.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T044616.20200312
- Date of decision
- 12 March 2020
- Case number
- T 0446/16
- Petition for review of
- -
- Application number
- 03003632.1
- IPC class
- A61L 2/00
- Language of proceedings
- German
- Distribution
- No distribution (D)
- Download
- Decision in German
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
- Applicant name
- CSL Behring GmbH
- Opponent name
- Octapharma AG
Biotest AG - Board
- 3.3.10
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)Rules of procedure of the Boards of Appeal Art 12(4) (2007)Rules of procedure of the Boards of Appeal Art 13 (2020)Rules of procedure of the Boards of Appeal Art 25 (2020)
- Keywords
- Neuheit - (ja)
Erfinderische Tätigkeit - (ja)
Ausreichende Offenbarung - (ja)
Spät eingereichte Beweismittel - Catchword
- -
- Citing cases
- -
Entscheidungsformel
Aus diesen Gründen wird entschieden:
Die Beschwerden werden zurückgewiesen.